MHC class I-presented tumor antigen appraisable for T-cell responses against ovarian cancer. - Jing Yao Wang; Nan Zhang; Xiaojie Yang; Danli Gao; Lirong Yin; Shuying Ji (Bangladesh Journal of Pharmacology, 2015)